BP11106 PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 2.0–3.0 dl/g, Mw: 118–198 kDa

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 2.0–3.0 dl/g, Mw: 118–198 kDa Description

This polymer is synthesised via ring-opening polymerisation of trimethylene carbonate and terminates with hydroxyl groups, offering reactive sites for chemical modification. The specified intrinsic viscosity and molecular weight provide controlled mechanical performance and degradation rates, critical for biomedical devices and implantable systems. Its defined molecular structure supports consistent processing and facilitates uniform film formation, which are advantageous in high-precision applications.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 2.0–3.0 dl/g, Mw: 118–198 kDa Applications

1.         Healthcare
- Used as a scaffold material in tissue engineering to achieve controlled biodegradation by leveraging its uniform molecular weight and hydroxyl termination.
- Applied as a drug delivery matrix in implantable devices to enable regulated release profiles by utilising its predictable degradation behaviour.

2.         Industrial
- Employed as a binder in biodegradable adhesives to attain environmentally compatible solutions by exploiting its tunable mechanical properties and biocompatibility.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 2.0–3.0 dl/g, Mw: 118–198 kDa Packing

This material is packaged in moisture-resistant, sealed containers with desiccant packs to prevent contamination and degradation. The packaging includes an inner protective lining to mitigate mechanical stress during transport. Products are stored under controlled temperature and humidity conditions to preserve material integrity. Custom packaging options, including vacuum-sealed and anti-static solutions, are available to meet specific storage and handling requirements.

Additional Information

PTMC, Poly(trimethylene carbonate), is a biodegradable and biocompatible polymer widely studied in the field of biomedical materials. Known for its amorphous nature, it exhibits excellent biocompatibility and biodegradability, and remains in a rubbery state with inherent elasticity at body temperature. Its adjustable degradation profile and processability make it well-suited for applications such as soft tissue engineering, flexible implants, and controlled drug delivery systems. Understanding the relationship between its molecular weight and intrinsic viscosity is essential for tailoring its performance in specific biomedical and industrial contexts.

The presence of hydroxyl end groups provides reactive sites for further chemical modification, covalent conjugation, or chain extension, thereby enhancing its versatility in synthesising block copolymers, cross-linked networks, and functionalised biomaterials. This reactive functionality expands its utility in advanced manufacturing, formulation processes, and the development of customised polymeric systems. Ongoing research continues to refine processing techniques to enhance its performance, reliability, and reproducibility across a growing range of applications.

Regulatory Note: This material is intended for industrial and research applications. It is the customer's responsibility to ensure compliance with all relevant safety and regulatory standards in their intended use.